Annals of Thoracic Medicine
REVIEW ARTICLE
Year
: 2022  |  Volume : 17  |  Issue : 3  |  Page : 137--144

Post-COVID lung disease(s)


Michel Achkar, Omar Jamal, Toufic Chaaban 
 Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University; Department of Internal Medicine, Lebanese American University Medical Center, Rizk Hospital, Beirut, Lebanon

Correspondence Address:
Dr. Toufic Chaaban
The Lau Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University Medical Center- Rizk hospital, Zahar Street, Ashrafieh, Beirut; Department of Internal Medicine, Lebanese American University Medical Center, Rizk Hospital, Beirut
Lebanon

Post-COVID lung impairment and diseases are major public health concern in the pandemic of COVID-19. Multiple etiological factors can lead to post-COVID respiratory symptoms, with post COVID fibrosis or diffuse parenchymal lung disease being the major concern. We searched PubMed database for English literature related to post-COVID lung disease and we summarized the existing evidence on radiological, physiological, and histopathological aspects of post-COVID lung diseases. We suggest a guidance on the evaluation of these patients and highlight management considerations including general care, pulmonary rehabilitation, and lung transplantation. We also explain gaps in knowledge and awaited ongoing research results, especially in the field of drug therapies including corticosteroids and antifibrotics.


How to cite this article:
Achkar M, Jamal O, Chaaban T. Post-COVID lung disease(s).Ann Thorac Med 2022;17:137-144


How to cite this URL:
Achkar M, Jamal O, Chaaban T. Post-COVID lung disease(s). Ann Thorac Med [serial online] 2022 [cited 2022 Aug 9 ];17:137-144
Available from: https://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2022;volume=17;issue=3;spage=137;epage=144;aulast=Achkar;type=0